HS_SW01
/ Shenzhen Huishan Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 28, 2026
HS_SW01: Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Primary Ovarian Insufficiency
(clinicaltrials.gov)
- P1/2 | N=21 | Not yet recruiting | Sponsor: Shenzhen Huishan Biotechnology Co., Ltd.
New P1/2 trial • Endocrine Disorders • Women's Health
April 18, 2026
HS_SW01: Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis
(clinicaltrials.gov)
- P1/2 | N=21 | Not yet recruiting | Sponsor: Shenzhen Huishan Biotechnology Co., Ltd.
New P1/2 trial • Immunology • Scleroderma • Systemic Sclerosis
April 17, 2026
HS_SW01: A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis
(clinicaltrials.gov)
- P1/2 | N=18 | Not yet recruiting | Sponsor: Shenzhen Huishan Biotechnology Co., Ltd.
New P1/2 trial • Ankylosing Spondylitis • Immunology • Inflammatory Arthritis • Rheumatology • Seronegative Spondyloarthropathies
1 to 3
Of
3
Go to page
1